Memidis Pharma introduces SwimCount Harvester™: innovative sperm purification technology for fertility treatment
Memidis Pharma has expanded its product range with the SwimCount™ Harvester, an advanced sperm purification device designed to optimize the selection of high-quality, progressively motile sperm cells (PMSCs). With this, Memidis Pharma expands its proton portfolio within fertility and makes an innovative technology available in fertility treatments.
Efficient and natural selection of sperm cells
The SwimCount™ Harvester uses a patented membrane technology that mimics the natural selection processes of the female reproductive tract. This ensures that only the most motile and morphologically healthy sperm are selected, which is essential for successful fertilization in procedures such as intrauterine insemination (IUI), in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI).
User-friendly and time-saving
Compared to traditional methods such as density gradient centrifugation (DGC), the SwimCount™ Harvester offers a simplified process with only four steps. This reduces the chance of errors and significantly shortens preparation time, while maintaining the integrity and functionality of the sperm cells.
Availability in the Benelux
Memidis Pharma is the exclusive distributor of the SwimCount™ Harvester in the Benelux. With the addition of the Swimcount Harvester to the Memidis product portfolio, an innovative technology becomes available for IVF clinics and hospitals for fertility treatments.
Learn more
For more details about the SwimCount™ Harvester and other products from Memidis Pharma, visit Swimcount Harvester
